The global transradial access devices market is projected to reach USD 2.18 billion by 2022 from USD 1.52 billion in 2017, at a CAGR of 7.5% during the forecast period.

The key factors driving the growth of this market are growing prevalence of lifestyle diseases, increasing preference for interventional procedures using radial artery access, growing utilization of radial access devices in the treatment of pediatric patients and increasing number of chemotherapy procedures.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=14566259

On the basis of product, the transradial access devices market is segmented into catheters, guidewires, sheaths and sheath introducers, and accessories. Catheters accounted for the largest as well as the fastest growing products in the transradial access devices market. Key factors driving the growth of this product segment are the increasing number of interventional and angiography procedures worldwide, and the increasing incidence of lifestyle-related diseases such as CVD, obesity, and diabetes.

On the bases of application, transradial access devices market is segmented as drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing. Drug administration accounted for the largest share of the transradial access devices market in 2017. This is also the fastest growing segment. The growth of this market segment can be attributed to the high usage of vascular access devices for drug administration, particularly for the treatment of infections and cancer.

On the bases of end users, transradial access devices market is segmented as hospitals, clinics and ambulatory care centers, and other end users. Hospitals, accounted for the largest share of the transradial access devices market, it is also the fastest growing segment.

On the bases of region, transradial access devices market is segmented North America, Europe, Asia Pacific, and the Rest of the World. North America is accounted for the largest share and is the fastest growing region of the transradial access devices market. Key factors driving the growth of this regional market are the growing prevalence of CVDs, increase in research and clinical trials for vascular access devices, and the rising number of conferences and workshops in this region.